Jade Biosciences, Inc. · NASDAQ:JBIO
BlackRock, Inc.'s stake in Jade Biosciences, Inc. fell to 4.70% (Schedule 13G/A)
Event Mar 31, 2026 · Filed Apr 27, 2026
BlackRock, Inc.'s stake in Jade Biosciences, Inc. fell to 4.70%, 2,295,825 shares, as a passive investor on Mar 31, 2026. Filed Apr 27, 2026 (Schedule 13G/A).
- Stake
- 4.70%
- Shares
- 2,295,825
- Intent
- Passive
- What changed
- Fell below 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 4.70% | 2,295,825 |
Source
Related
- Jade Biosciences, Inc.
- BlackRock, Inc.
- Jade Biosciences, Inc. shareholders
- Schedule 13G/A · BlackRock, Inc. · Oct 17, 2025
- Schedule 13G · BlackRock, Inc. · Jul 17, 2025
- Schedule 13G/A · Venrock Healthcare Capital Partners III, L.P. · Aug 14, 2026
- Schedule 13G/A · Bellevue Group AG · Aug 14, 2026
- Schedule 13G · Paradigm Biocapital Advisors LP · Jul 17, 2026
- Schedule 13G/A · Janus Henderson Group PLC · Jul 8, 2026
- Schedule 13D/A · Fairmount Funds Management LLC · Jun 9, 2026